Cargando…

Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial

In this randomized, double-blind, controlled, parallel group study (ZENITH), 434 essential hypertensives with additional cardiovascular risk factors, uncontrolled by a previous monotherapy, were treated for 18 weeks with zofenopril 30 or 60 mg plus hydrochlorothiazide (HCTZ) 12.5 mg or irbesartan 15...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malacco, Ettore, Omboni, Stefano, Parati, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540998/ https://www.ncbi.nlm.nih.gov/pubmed/26347187 http://dx.doi.org/10.1155/2015/139465

Ejemplares similares

Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2014)

Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies
por: Omboni, Stefano, et al.
Publicado: (2017)

Erratum to: Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized “Z” Studies
por: Omboni, Stefano, et al.
Publicado: (2017)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Cardioprotective role of zofenopril in patients with acute myocardial infarction: a pooled individual data analysis of four randomised, double-blind, controlled, prospective studies
por: Borghi, Claudio, et al.
Publicado: (2015)

Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study
por: Borghi, Claudio, et al.
Publicado: (2018)

Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
por: Borghi, Claudio, et al.
Publicado: (2006)

Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies
por: Borghi, Claudio, et al.
Publicado: (2018)

Zofenopril and incidence of cough: a review of published and unpublished data
por: Omboni, Stefano, et al.
Publicado: (2011)

Effects of Treatment with Zofenopril in Men and Women with Acute Myocardial Infarction: Gender Analysis of the SMILE Program
por: Franconi, Flavia, et al.
Publicado: (2014)

Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies
por: Borghi, Claudio, et al.
Publicado: (2018)

Efficacy of Ace Inhibition with Zofenopril, Lisinopril, or Ramipril in Postacute Myocardial Infarction Patients With or Without Metabolic Syndrome: A Pooled Individual Data Analysis of Four Randomized, Double-Blind, Controlled, Prospective Studies
por: Borghi, Claudio, et al.
Publicado: (2017)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
por: Omboni, Stefano, et al.
Publicado: (2015)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide
por: Khodke, Amol S, et al.
Publicado: (2010)

Efficacy of Zofenopril Compared With Placebo and Other Angiotensin-converting Enzyme Inhibitors in Patients With Acute Myocardial Infarction and Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis of 4 Randomized, Double-blind, Controlled, Prospective Studies
por: Borghi, Claudio, et al.
Publicado: (2017)

Simultaneous Analysis of Irbesartan and Hydrochlorothiazide: An Improved HPLC Method with the Aid of a Chemometric Protocol
por: Vujić, Zorica, et al.
Publicado: (2012)

Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination
por: Parati, Gianfranco, et al.
Publicado: (2018)

Efficacy and Safety of a Fixed Combination of Irbesartan/Hydrochlorothiazide in Chinese Patients with Moderate to Severe Hypertension
por: Huang, Qi-Fang, et al.
Publicado: (2013)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
por: Flack, J M
Publicado: (2007)

Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study
por: Borghi, Claudio, et al.
Publicado: (2016)

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
por: Brown, Morris J, et al.
Publicado: (2016)

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
por: Mullen, Michael, et al.
Publicado: (2019)

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
por: Borghi, Claudio, et al.
Publicado: (2013)

Early Treatment With Zofenopril and Ramipril in Combination With Acetyl Salicylic Acid in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results of a 5-Year Follow-up of Patients of the SMILE-4 Study
por: Borghi, Claudio, et al.
Publicado: (2017)

Comparison of clinical efficacy of metoprolol combined with irbesartan and hydrochlorothiazide and non-invasive ventilator in the emergency treatment of patients with severe heart failure
por: Zhang, Fangxia, et al.
Publicado: (2018)

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy
por: Punzi, Henry, et al.
Publicado: (2012)

Zofenopril: Blood pressure control and cardio-protection
por: Borghi, Claudio, et al.
Publicado: (2022)

Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
por: Borghi, Claudio, et al.
Publicado: (2008)

Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD
por: Jiang, Gui-yun, et al.
Publicado: (2018)

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
por: Rhee, Moo-Yong, et al.
Publicado: (2015)

Randomised comparison of zofenopril and ramipril plus acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a post hoc analysis of the SMILE-4 Study in patients according to levels of left ventricular ejection fraction at entry
por: Borghi, Claudio, et al.
Publicado: (2015)

Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial
por: Zhao, Jing, et al.
Publicado: (2022)

Monotherapy with amlodipine or hydrochlorothiazide in patients with mild to moderate hypertension: Comparison of their efficacy and effects on electrolytes
por: Nwachukwu, Daniel C, et al.
Publicado: (2017)

Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial
por: Kongtharvonskul, Jatupon, et al.
Publicado: (2016)

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
por: Derosa, Giuseppe, et al.
Publicado: (2018)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial
por: Danila, Maria I., et al.
Publicado: (2022)

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy
por: Ahn, Youngkeun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mfkieg97lutmuashfh2ulg543b